The high risk of mold contamination in biopharmaceutical facilities: gypsum wall materials versus uPVC wall panels â regulatory scrutiny, recalls and facility shutdowns
{{output}}
Mold contamination in biopharmaceutical manufacturing is a serious patient-safety, product-quality and regulatory risk. This paper reviews the mechanisms by which wall construction materials contribute to microbial ingress and colonization, compares traditiona... ...
